Tirzepatide Weight Loss Results In the landmark SURMOUNT-1 trial published in the New England Journal of Medicine , participants receiving the highest dose of tirzepatide (15 mg weekly) achieved an average reduction of approximately 20.9% of body weight over 72 weeks
Who Should Proceed With Caution Men with a history of hormone-sensitive cancers Those with uncontrolled diabetes or significant metabolic disease Men with active cardiovascular conditions Anyone with pituitary disorders Those taking medications that may interact with hormone therapies What to Expect: Timeline of Results Results from a peptide and TRT stack develop progressively: Individual timelines vary based on starting hormone levels, age, training status, and adherence to the protocol
To explore if Tirzepatide injections might be a suitable part of your health journey, please dont hesitate to contact us or book an appointment online
Thats why we regularly assess the effectiveness of your medication, making necessary adjustments to ensure your treatment evolves with you
83 Furthermore, Bredella et al
If NAION is confirmed, the ophthalmologist will assess for arteritic features requiring urgent laboratory testing (ESR, CRP, platelets) and possible immediate corticosteroid therapy if giant cell arteritis is suspected
